Wilmington, MA pharmaceutical company,  CutisPharma announced today that the US Food and Drug Administration (FDA) has approved FIRVANQ™ (vancomycin hydrochloride) for oral solution, for the treatment...

GenePOC Inc announced today that its Clostridium difficile assay,  GenePOC™ CDiff, for use on the revogene™ instrument, received clearance from the US Food and Drug Administration (FDA). The GenePOC...

On the Sunday, Nov. 12 airing of the Outbreak News This Week Radio Show, several important topics were covered to include Clostrifium difficile infection (CDI), pandemic preparedness and a look back...

November is Clostridium difficile Awareness Month . The C. diff foundation says over 41 individuals lose their life to a Clostridium difficile infection (CDI) in the United States of America alone every...

Outpatient antibiotic use is a primary risk factor for acquiring Clostridium difficile infection in the community, reinforcing the need for appropriate prescribing in this setting, a new study published...

Misuse and overuse of antimicrobials is one of the world’s most pressing public health problems. Infectious organisms adapt to the antimicrobials designed to kill them, making the drugs ineffective....

Investigators have revealed that the Gram-positive, anaerobic bacterium Clostridium difficile is widely distributed in soil samples from children’s and dogs’ sandboxes located within the...

Researchers from the Perelman School of Medicine at the University of Pennsylvania have found evidence that the most difficult C. difficile cases, known as multiple recurring C. difficile infections...

Intestinal infection with the bacterium Clostridium difficile is the most frequent healthcare-linked infection in the United States. Each year it afflicts about half a million Americans, causes tens...

According to the Centers for Disease Control and Prevention (CDC), on any given day, about one in 25 hospital patients has at least one healthcare-associated infection (HAI). Clearly, HAIs are a huge problem...